Kiko “Kla” ta nifiká?
E animal no ta karga e mutashon. E no lo desaroyá e malesa i lo no pasa esaki.
Kachó Síndrome Miasténico Congénito Den Heideterrier (CMS-H)
Discover the importance of the DNA test for Congenital Myasthenic Syndrome (CMS) in Heideterriers, a hereditary neuromuscular disorder affecting this unique dog breed. Early genetic screening helps breeders identify carriers and prevent the transmission of CMS, ensuring healthier litters. This precise DNA test detects mutations linked to CMS, allowing for informed breeding decisions and improved canine health. Regular testing supports responsible breeding practices and enhances the overall well-being of Heideterriers. Protect your dog’s future by choosing reliable CMS DNA testing today. Stay proactive in managing congenital health risks with advanced genetic tools.
Abreviashon : CMS-H
Mutashon analisá : CHRNE c.1436_1437insG
Herensha : Autosomal Resesivo
Sigla
CMS-H
Frekuensha opservá
Severidat klíniko
Klasifikashon klíniko
Malesanan Neuromuskular
Mutashon analisá
CHRNE c.1436_1437insG
p.(S503Rfs*14)
p.(S503Rfs*14)
Modo di herensia
Autosomal Resesivo
Resumen di prueba:
The DNA test for Congenital Myasthenic Syndrome (CMS) in Heideterriers helps identify genetic mutations responsible for this inherited neuromuscular disorder. CMS causes muscle weakness and fatigue due to impaired nerve-to-muscle communication. Early detection through genetic testing enables breeders to make informed decisions and reduce the risk of passing the condition to offspring. This test is essential for maintaining the health and vitality of the Heideterrier breed. Regular screening supports responsible breeding and improves overall canine welfare.
Obtenibel for di e pakete : Basic
E tèst di DNA aki ta inkluí kuminsando for di nos pakete Basic — i tambe ta parti di e paketenan Basic, Standard, Advanced, Complete.
Wak e paketenan di tèst di DNA →Skohe e pakete ku ta pas mihó ku bo strategia di krio òf salú di bo bestianan.
Overview of Congenital Myasthenic Syndrome (CMS)
Congenital Myasthenic Syndrome (CMS) is a group of inherited neuromuscular disorders characterized by weakness and fatigue of voluntary muscles. This condition results from defects in the transmission of nerve impulses to muscles, leading to compromised muscle function. It is caused by genetic mutations that affect the proteins responsible for neuromuscular transmission, notably at the neuromuscular junction where nerve cells communicate with muscles.
Symptoms of CMS in Dogs
Dogs affected by CMS may exhibit a range of symptoms, including muscle weakness, exercise intolerance, and fatigue. Some dogs may also show signs of difficulty in swallowing, facial muscle weakness, and a tendency to collapse after exertion. These symptoms can vary in severity and may be mistaken for other conditions, making a proper diagnosis crucial for effective management.
Importance of DNA Testing for CMS
DNA testing plays a vital role in identifying genetic mutations associated with Congenital Myasthenic Syndrome. By analyzing specific genes known to be linked to CMS, veterinarians and breeders can better understand the genetic predisposition of individual dogs. This information is crucial for making informed breeding decisions and helps in managing the condition in affected dogs.
Opshonnan di Maneho i Tratamentu
Currently, there is no cure for Congenital Myasthenic Syndrome; however, management strategies are available to improve the quality of life for affected dogs. Treatment often includes the use of medications such as anticholinesterase agents, which can enhance neuromuscular transmission. Supportive care, including physical therapy and nutritional management, is also essential to help maintain muscle function and overall health.
Konklushon
Congenital Myasthenic Syndrome is a serious condition that can significantly affect the life of a dog. Early diagnosis through DNA testing can facilitate proper management and care, ensuring that affected dogs receive the support they need to lead a fulfilling life. Understanding the implications of this condition is vital for dog owners, breeders, and veterinary professionals alike.
Rasa rekonosé pa e tèst: Síndrome Miasténico Congénito Den Heideterrier (CMS-H)
- Heideterrier
- Smooth Fox Terrier
🧬 Interpretation of genotypes CMS-H
Genotipo
Estado
🟡 N/N
No-transportador - Sin Riesgo
🟡 N/CMS-H
Transportadó - Sin Riesgo
❌ CMS-H/CMS-H
Afektá - Na Riesgo
FAQ: komprondementu di e interpretashon
Un “Transportadó” ta serio?
No. E animal ta generalmente salú pero por transmití e mutashon na su yu.
Kiko si un bestia ta “Afektá”?
E ta karga dos kopia mutá. Ta spera señalnan klíniko dependiendo di e malesa. E no mester wòrdu kriá.
Dikon tin diferensia entre hòmber/muhé?
Algun malesa ta mará na sekso, pues nan ekspreshon ta varia dependiendo di e sekso di bestia.
Pronostiká Desendiente
N/N (no-transportador) )
N/CMS-H (Transportador) )
CMS-H/CMS-H (Afektá) )
FAQ di Prueba di DNA
Kiko e tèst di DNA aki ta detektá?
This DNA test detects the mutation associated with Congenital Myasthenic Syndrome In Heideterrier (CMS-H) in order to identify clear, carrier, or at-risk animals.
Dikon tèst un bestia di krio?
Prueba di DNA ta yuda kriadónan plania parehamentu mas sigur i redusí e riesgo di transmití e mutashon na yunan.
Kiko ta e moda di herensia di e tèst aki?
E moda di herensia raportá pa e tèst aki ta Outosomal Resesivo.
Kua mutashon ta wòrdu analisá den e tèst aki?
This test analyses the mutation CHRNE c.1436_1437insG.
Un bestia kargadó ta nesesariamente afektá?
No nesesariamente. Interpretashon ta dependé di e patronchi di herensia i e genotipo resultante.
Referensianan
Herder Vanessa, Ciurkiewicz Malgorzata, Baumgärtner Wolfgang, Jagannathan Vidhya, Leeb Tosso. Frame-shift variant in the CHRNE gene in a juvenile dog with suspected myasthenia gravis-like disease. Anim Genet. 2017 Oct;48(5):625. doi: 10.1111/age.12558. Epub 2017 May 16.